Canada – Amendments to the Medical Devices Regulations to address future public health emergencies

On February 22, 2023, the Regulations Amending the Medical Devices Regulations (Interim Order No. 3 Respecting the Importation and Sale of Medical Devices for Use...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-7 Guidance on exemptions from the requirement to perform clinical investigations...

In the case of implantable devices and class III devices, clinical investigations shall be performed, except if: — the device has been designed by modifications of...
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) - updated information

Switzerland – New organisational structure with separate Medical Devices Surveillance Sector

For the strategy period 2023-2026, Swissmedic’s objectives include making legal responsibilities for medical devices more visible and stepping up international collaboration in this area....

UK – Heart vests to identify those at high risk of sudden cardiac death

In the UK, heart rhythms affect around two million people and can cause sudden death. A re-useable heart vest developed by researchers from University College...

UK- Wearable technology to be offered to thousands with type 1 diabetes in UK

The condition affects around 270,935 people in England and 16,090 people in Wales. The National Institute for Health and Care Excellence (NICE) has published final...
Special 510(k)s: CDRH’s Proposed Program Expansion Draws Mixed Reactions

USA – FDA updates third party 510(k) guidance

The US Food and Drug Administration (FDA) has published a draft guidance that updates a 2020 final guidance on its third party 510(k) review...

Europe – The clock is ticking – MedTech Europe’s recommendations ahead of May 2025...

Class D IVDs are critical for public health. They mainly fall into two categories: a) those related to blood, cells, tissues or organ screening,...

Europe – Questions & Answers for applicants, marketing authorisation holders of medicinal products and...

This Question and Answer (Q&A) document provides practical considerations concerning the implementation of the medical devices and the in vitro diagnostic medical devices regulations. This...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – MDCG 2023-6 Guidance on demonstration of equivalence for Annex XVI products :...

The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR (medical device regulation), provides a possibility to use clinical data related...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – MDCG 2023-5 – Guidance on qualification and classification of Annex XVI products...

The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR, is applicable to the groups of products without an intended medical...

NOS PROCHAINES FORMATIONS